Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data DarkPulse, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
0
0
0
0
0
7.78
9.1
2.02
0.13
0.31
Cost of revenue
0
6.69
14.5
2.45
0
0.1
Gross profit
0
1.1
-5.44
-0.43
0.12
0.21
Research and development
0
0.03
0.09
0
General and administrative
0.26
0.02
0.22
0.18
0.15
3.92
4.97
2.03
0.47
0.88
Operating expenses
0.27
0.11
2.54
0.55
0.26
9.95
29.6
20.5
2
2.65
Operating income
-0.27
-0.11
-2.54
-0.55
-0.26
-8.85
-35.1
-20.9
-1.88
-2.44
Interest expense
0
0.03
0.53
0.51
0.14
0.13
0.62
0.64
0.63
0.14
Other non-operating income
-0
-0.03
-0.78
-1.28
-0.02
4.02
-0.45
-0.8
-2.02
-0.48
Pre-tax income
-0.27
-0.22
-4.29
-13.1
-18.8
-18.8
-18.8
Income tax
-0
0.04
0
Net income to minority interests
-0.01
0
0
0
-0.13
-0.24
-0.9
-0.01
0.04
Net income
-0.27
-0.14
-3.32
-1.83
-0.28
-4.69
-35.3
-20.8
-3.88
-2.97
EBITDA
-0.24
-0.08
-2.49
-0.5
-0.17
-8.59
-33.5
-20.4
-1.75
-2.35
EPS, basic
0.00
-1,279.00
-0.04
0.00
0.00
0.00
-0.01
0.00
0.00
-0.04
EPS, diluted
0.00
-1,279.00
-0.04
0.00
0.00
0.00
-0.01
0.00
0.00
-0.04
Shares, basic (weighted)
58.4
0
89.7
488
2,323
4,776
5,713
7,411
8,214
Shares, diluted (weighted)
58.4
0
89.7
488
2,323
4,776
5,713
7,411
8,214
72
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
0
0.01
0.07
0
0
3.66
2.06
0.01
0.09
0.06
Receivables
0
4.53
2.95
0.87
0.92
0.42
Inventory
0
0.01
0.02
0
0
Other current assets
0
0
0
0
0.18
0.18
0.08
0.1
0.06
Total current assets
0
0.02
0.07
0
0
8.87
6.97
0.96
1.1
0.54
Property, plant and equipment
0
0
1.79
1.93
0.74
0.7
0.55
Lease right-of-use assets
0
2.62
2.72
0.5
0.45
0
Goodwill
0
17.1
6.46
0
0.02
0
Intangible assets
0.63
0.54
0.49
0.45
0
3.89
0.39
0
0
0
Other non-current assets
0.01
0.07
0.12
0.09
0.84
0.69
0.16
0.31
0.13
Total assets
0.63
0.56
0.63
0.56
0.49
35.4
22
4.11
2.79
1.37
Accounts payable
0.38
0.01
0.06
0.32
0.52
8.68
13.7
16.9
15.2
Accrued liabilities
0.51
0.03
0.34
0.5
0
2.06
1.94
0
3.78
Deferred revenue
0.04
0.04
0
6.02
2.22
0
0
0
Total current liabilities
0.94
0.08
1.74
3.22
3.24
19.7
18.5
19.1
18.3
20.3
Lease liabilities
0
2.47
2.55
0.5
0.45
0
Other non-current liabilities
0
0.13
0
Total liabilities
0.94
1.27
2.85
4.37
4.42
23.9
22.4
20.8
19.8
20.9
Total debt
1.1
1.16
1.16
1.17
1.09
1.1
1.04
0.61
Paid-in capital
18.3
0
0.86
-11.9
1.81
20.2
44.6
49.7
52.2
53.9
Retained earnings
-19.3
-1.03
-4.35
-6.17
-6.45
-11.3
-46.6
-67.4
-71.3
-74.2
Treasury stock
-0
0
-0
-0
-0
-0
-0
-0
-0
-0
Other comprehensive income
0.3
0.39
0.34
0.32
-0.28
-1.14
-1.25
-1.63
-2.4
Shareholders' equity
-0.53
-0.71
-2.22
-3.81
-3.93
11.6
-0.33
Minority interests
-0.01
2.36
1.22
1.21
1.25
Total equity
-0.53
-0.71
-2.22
-3.81
-3.93
11.6
-0.33
-16.7
-17
-19.5
Total liabilities and equity
0.63
0.56
0.63
0.56
0.49
35.4
22
4.11
2.79
1.37
Shares outstanding
59.7
0
89.7
1,392
4,089
5,198
6,427
8,100
40.5
90.9
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-0.27
-0.14
-1.69
-1.83
-0.28
-4.83
-35.5
-21.7
-3.89
-2.93
Depreciation and amortization
0.03
0.03
0.05
0.05
0.09
0.26
1.57
0.52
0.13
0.09
Stock-based compensation
0
0
1.6
0.14
0
0.6
0
Deferred income tax
0
0
0
0.01
Change in receivables
0
0.77
1.5
-1.76
-0.05
-0.15
Change in inventory
0
-0.01
-0.01
0.02
0
Change in payables
0.04
0.01
0.05
0.26
0.2
-2.04
-2.61
4.8
1.36
1.95
Cash from operations
-0.1
-0.02
-0.89
-0.17
0.01
-11.4
-21.7
-5.65
-1.51
-0.07
Capital expenditures
0
-0.75
-2.07
-0.1
-0.03
0
Acquisitions
0
-0.58
0
Purchases of investments
-1.5
-1.5
Cash from investing
-0.04
-0.01
-0.1
-0.05
-0
-1.69
-5.05
-0.22
-0.09
0
Stock issued
0.07
0.05
0
14.6
24.3
3.5
3.95
1.17
Cash from financing
0.08
0.04
1.06
0.16
-0
17.3
24.2
3.63
2.08
0.95
Net change in cash
-0.07
-0
4.26
-2.62
-2.24
0.47
0.88
Free cash flow
0.01
-12.1
-23.8
-5.76
-1.55
-0.07
Interest paid
0
0
0
0
0
0
0
0.05
0.02
0.03
Income taxes paid
0
0
0
0
0
0
0
0
0
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.01 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
98.5%
Gross profit / revenue.
Operating margin
-1,519.0%
Operating income / revenue.
EBITDA margin
-1,479.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-2,019.0%
Net income / revenue.
Operating cash flow margin
-882.5%
Cash from operations / revenue.
Return on assets (ROA)
-224.4%
Net income / average total assets.
D&A / revenue
40.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
143.2%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-67.6%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y
68.3%
Gross profit vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-50.9%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-60.4%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
23.0%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
-99.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
-76.7%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-50.1%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.03x
Current assets / current liabilities.
Quick ratio
0.02x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.00x
(Cash + short-term investments) / current liabilities.
Debt / assets
35.0%
Total debt / total assets.
Liabilities / assets
1,528.0%
Total liabilities / total assets.
Net debt
$397.9K
Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage
-9.65x
Operating income / interest expense.
Working capital
-$20.0M
Current assets - current liabilities.
Goodwill and intangibles / assets
1.1%
(Goodwill + intangible assets) / total assets.
Efficiency
Metric
Value
How it is calculated
Asset turnover
0.11x
Revenue / average total assets.
Fixed asset turnover
0.28x
Revenue / average property, plant and equipment.
Receivables turnover
0.36x
Revenue / average receivables.
Days sales outstanding
1,023 days
365 x average receivables / revenue.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.02
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Market cap + total debt - cash - short-term investments.
P/S
8.15x
Market cap / revenue.
EV/Sales
10.8x
Enterprise value / revenue.
Earnings yield
-247.7%
Net income / market cap (the inverse of P/E).
What was DarkPulse, Inc.'s revenue in fiscal 2025?
DarkPulse, Inc. reported revenue of $308.5K for fiscal 2025, 143.2% higher than the year before.
Was DarkPulse, Inc. profitable in fiscal 2025?
No. It reported a net loss of $3.0M.
How much free cash flow did DarkPulse, Inc. generate in fiscal 2025?
Cash from operations of $66.5K minus capital expenditures of $0.0 left free cash flow of -$66.5K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.